Skip to main content Accessibility help
  • Print publication year: 2010
  • Online publication date: July 2010

17 - Vitrification of human oocytes using the McGill Cryoleaf protocol

from Section 4 - Cryopreservation of oocytes


Advances in assisted reproductive technology (ART) have created opportunities for preservation of the reproductive potential of young males with cancer. Semen cryopreservation is possible in most adolescents with cancer regardless of age or diagnosis. Awareness by physicians is even more essential when dealing with younger populations. Theoretically, testicular tissue from prepubertal boys facing gonadotoxic treatment could be banked for many years for spermatogonial stem cell transplantation. Male germline stem cells are the only cells in postnatal mammals that undergo self-renewal and transmit genes to subsequent generations, since all female germline stem cells cease their proliferation before birth. Future possible methods of restoring fertility might include the derivation of mature sperm cells from human embryonic stem cells. Embryoid bodies were shown to support maturation of the primordial germ cells into haploid male gametes, which when injected into oocytes round off the somatic diploid chromosome complement and develop into blastocysts.

Related content

Powered by UNSILO


1. LeeSJ, SchoverLR, PartridgeAH, et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 2006; 24: 2917–2931.
2. Ethics Committee of the American Society of Reproductive Medicine. Fertility preservation and reproduction in cancer patients. Fertil Steril 2005; 83: 1622–1628.
3. WangX, ChenH, YinH, et al. Fertility after intact ovary transplantation. Nature 2002; 415: 385.
4. OktayK, BuyukE, VeeckLL, et al. Embryo development after heterotopic transplantation of cryopreserved ovarian tissue. Lancet 2004; 363: 837–840.
5. DonnezJ, DolmansMM, DemylleD, et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 2004; 364: 1405–1410.
6. MeirowD, LevronJ, Eldar-GevaT, et al. Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy. N Engl J Med 2005; 353: 318–321.
7. DemeestereI, SimonP, EmilianiS, DelbaereA, EnglertY.Fertility preservation: successful transplantation of cryopreserved ovarian tissue in a young patient previously treated for Hodgkin’s disease. Oncologist 2007; 12: 1437–1442.
8. MeirowD, HardanI, DorJ, et al. Searching for evidence of disease and malignant cell contamination in ovarian tissue stored from hematologic cancer patients. Hum Reprod 2008; 23: 1007–1013.
9. Practice Committee of the American Society of Reproductive Medicine. Ovarian tissue and oocyte cryopreservation. Fertil Steril 2004; 82: 993–998.
10. KuleshovaLL, LopataA.Vitrification can be more favorable than slow cooling. Fertil Steril 2002; 78: 449–454.
11. OktayK, CilAP, BangH.Efficiency of oocyte cryopreservation: a meta-analysis. Fertil Steril 2006; 86: 70–80.
12. HuangJY, TanSL, ChianR-C.Fertility preservation for female. J Reprod Contracept 2006; 17: 109–128.
13. ChianR-C, HuangJYJ, GilbertL, et al. Obstetric outcomes following vitrification of in-vitro and in-vivo matured oocytes. Fertil Steril 2009; 91: 2391–2398.
14. KatayamaKP, StehlikJ, KuwayamaM, KatoO, StehlikE.High survival rate of vitrified human oocytes results in clinical pregnancy. Fertil Steril 2003; 80: 223–224.
15. KuwayamaM, VajtaG, KatoO, LeiboSP.Highly efficient vitrification method for cryopreservation of human oocytes. Reprod Biomed Online 2005; 11: 300–308.
16. KuwayamaM.Highly efficient vitrification for cryopreservation of human oocytes and embryos: the Cryotop method. Theriogenology 2007; 67: 73–80.
17. LucenaE, BernalDP, LucenaC, et al. Successful ongoing pregnancies after vitrification of oocytes. Fertil Steril 2006; 85: 108–111.
18. CoboA, KuwayamaM, PerezS, et al. Comparison of concomitant outcome achieved with fresh and cryopreserved donor oocytes vitrified by the Cryotop method. Fertil Steril 2008; 89: 1657–1664.
19. CooperA, PaynterSJ, FullerBJ.Differential effects of cryopreservation on nuclear or cytoplasmic maturation in vitro in immature mouse oocytes from stimulated ovaries. Hum Reprod 1998; 13: 971–978.
20. IsachenkoEF, NayuduPL.Vitrification of mouse germinal vesicle oocytes: effect of treatment temperature and egg yolk on chromosomal normality and cumulus integrity. Hum Reprod 1999; 14: 400–408.
21. TothTL, BakaSG, VeeckLL, et al. Fertilization and in vitro development of cryopreserved human prophase I oocytes. Fertil Steril 1994; 61: 891–894.
22. TothTL, LanzendorfSE, SandowBA, et al. Cryopreservation of human prophase I oocytes collected from unstimulated follicles. Fertil Steril 1994; 61: 1077–1082.
23. SonWY, ParkSE, LeeKA, et al. Effects of 1,2-propanediol and freezing–thawing on the in vitro developmental capacity of human immature oocytes. Fertil Steril 1996; 66: 995–999.
24. TuckerMJ, WrightG, MortonPC, MasseyJB.Birth after cryopreservation of immature oocytes with subsequent in vitro maturation. Fertil Steril 1998; 70: 578–579.
25. RaoGD, ChianR-C, SonWS, GilbertL, TanSL.Fertility preservation in women undergoing cancer treatment. Lancet 2004; 363: 1829–1830.
26. HuangJY, TulandiT, HolzerH, TanSL, ChianR-C.Combining ovarian tissue cryobanking with retrieval of immature oocytes followed by in vitro maturation and vitrification: an additional strategy of fertility preservation. Fertil Steril 2008; 89: 567–572.
27. ChianR-C, GilbertL, HuangJYJ, et al. Live birth after vitrification of in vitro matured human oocytes. Fertil Steril 2009; 91: 372–376.
28. ChianR-C, BuckettWM, TanSL.In-vitro maturation of human oocytes. Reprod Biomed Online 2004; 8: 148–166.
29. ChianR-C, LimJH, TanSL.State of the art in in-vitro oocyte maturation. Curr Opin Obstet Gynecol 2004; 16: 211–219.
30. JuremaMW, NogueiraD.In vitro maturation of human oocytes for assisted reproduction. Fertil Steril 2006; 86: 1277–1291.
31. Al-SunaidiM, TulandiT, HolzerH, et al. Repeated pregnancies and live births after in vitro maturation treatment. Fertil Steril 2007; 87: 1212.e9–e12.
32. SonW-Y, ChungJ-T, ChianR-C, et al. A 38 h interval between hCG priming and oocyte retrieval increases in vivo and in vitro oocyte maturation rate in programmed IVM cycles. Hum Reprod 2008; 23: 2010–2016.
33. EdwardsRG. Foreword. In TanSL, ChianR-C, BuckettWM, eds. In Vitro Maturation of Human Oocytes Basic Science to Clinical Application. London: Informa Healthcare, 2006, pp. xv–xx.
34. BuckettWM, ChianR-C, HolzerH, et al. Obstetric outcomes and congenital abnormalities after in vitro maturation, in vitro fertilization, and intracytoplasmic sperm injection. Obstet Gynecol 2007; 110: 885–891.
35. DemirtasE, ElizurS, HolzerH, et al. Immature oocyte retrieval in the luteal phase to preserve fertility in women with cancer facing imminent gonadotoxic therapy: it is worth a try. Reprod Biomed Online 2008; 17: 520–523.
36. LuyetB.The vitrification of organic colloids and protoplasm. Biodynamica 1937; 1: 1–14.
37. FahyG.Prospect for vitrification of whole organs. Cryobiology 1981; 18: 617–625.
38. MacFarlaneD, ForsythM.Recent insights on the role of the cryoprotection against vitrification. Cryobiology 1990; 27: 345–358.
39. SommerfeldV, NiemannH.Cryopreservation of bovine in vitro produced embryos using ethylene glycol in controlled freezing or vitrification. Cryobiology 1999; 38: 95–105.
40. EmilianiS, BerghM, VanninA, BiramaneJ, EnglertY.Comparison of ethylene glycol, 1,2-propanediol and glycerol for cryopreservation of slow-cooled mouse zygotes, 4-cell embryos and blastocysts. Hum Reprod 2000; 15: 905–910.
41. ShawJ, OranratnachaiA, TrounsonA.Fundamental cryobiology of mammalian oocytes and ovarian tissue. Theriogenology 2000; 53: 59–72.
42. MazurP.Cryobiology: the freezing of biological systems. Science 1970; 168: 939–949.
43. KasaiM.Advances in the cryopreservation of mammalian oocytes and embryos: development of ultrarapid vitrification. Reprod Med Biol 2002; 1: 1–9.
44. BoutronP, KaufmannA.Stability of the amorphous state in the system water–1,2-propanediol. Crybiology 1979; 16: 557–568.
45. RenardJ, BabinetC.High survival of mouse embryos after rapid freezing and thawing inside plastic straws with 1,2-propanediol as cryoprotectant. J Exp Zool 1984; 230: 443–448.
46. GlenisterP, WoodM, KirbyC, WhittinghamD.Incidence of chromosome anomalies in first-cleavage mouse embryos obtained from frozen–thawed oocytes fertilized in vitro. Gamete Res 1987; 16: 205–216.
47. KolaI, KirbyC, ShawJ, DaveyA, TrounsonA.Vitrification of mouse oocytes results in aneuploidy zygotes and malformed fetuses. Teratology 1988; 38: 467–474.
48. VincentC, PreliereG, Pajot-AugyE, et al. Effects of cryoprotectants on actin filaments during the cryopreservation of one-cell rabbit embryos. Cryobiology 1990; 27: 9–23.
49. GookD, OsbornS, BourneH, JohnstonW.Fertilization of human oocytes following cryopreservation; normal karyotypes and absence of stray chromosome. Hum Reprod 1994; 9: 684–691.
50. van BlerkomJ, DavisP.Cytogenic, cellular, and developmental consequences of cryopreservation of immature and mature mouse and human oocytes. Micro Res Tech 1994; 27: 165–193.
51. VincentC, JohnsonMH.Cooling, cryoprotectants, and the cytoskeleton of the mammalian oocyte. Oxford Rev Reprod Biol 1992; 14: 73–100.
52. GookD, OsbornS, JohnsonW.Cryopreservation of mouse and human oocytes using 1,2-propanediol and the configuration of the meiotic spindleHum Reprod 1993; 8: 1101–1109.
53. SathananthanAH, TrounsonA, FreemanL.Morphology and fertilization of frozen human oocytes. Gamete Res 1987; 16: 343–354.
54. ErogluA, TonerM, LeykinL, TothTL.Cytoskeleton and polyploidy after maturation and fertilization of cryopreserved germinal vesicle-stage mouse oocytes. J Assist Reprod Genet 1998; 15: 447–454.
55. ErogluA, TothTL, TonerM.Alterations of the cytoskeleton and polyploidy induced by cryopreservation of metaphase II mouse oocytes. Fertil Steril 1998; 69: 944–957.
56. HuangJY, ChenHY, TanSL, ChianR-C.Effects of osmotic stress and cryoprotectant toxicity on mouse oocyte fertilization and subsequent embryonic development in vitro. Cell Preserv Tech 2006; 4: 149–160.
57. AliJ, SheltonJ.Vitrification of preimplantation stages of mouse embryos. J Reprod Fertil 1993; 98: 459–465.
58. MukaidaT, WadaS, TakahashiK, et al. Vitrification of human embryos based on the assessment of suitable conditions for 8-cell mouse embryos. Hum Reprod 1998; 13: 2874–2879.
59. KasaiM, KomiJ, TakakamoA, et al. A simple method for mouse embryo cryopreservation in a low toxicity vitrification solution, without appreciable loss of viability. J Reprod Fertil 1990; 89: 91–97.
60. VajtaG, NagyZP.Are programmable freezers still needed in the embryo laboratory? Review on vitrification. Reprod Biomed Online 2006; 12: 779–796.
61. KuwayamaM, VajtaG, IedaS, KatoO.Comparison of open and closed methods for vitrification of human embryos and the elimination of potential contamination. Reprod Biomed Online 2005; 11: 608–614.
62. LaneM, BavisterB, LyonsE, ForestK.Container-less vitrification of mammalian oocytes and embryos. Nat Biotechnol 1999; 17: 1234–1236.
63. LaneM, SchoolcraftW, GardnerD.Vitrification of mouse and human blastocysts using a novel cryoloop container-less technique. Fertil Steril 1999; 72: 1073–1078.
64. VajtaG, HolmP, KuwayamaM, et al. Open pulled straw (OPS) vitrification: a new way to reduce cryoinjuries of bovine ova and embryos. Mol Reprod Dev 1998; 51: 53–58.
65. VanderzwalmenP, BertinG, DebaucheC, et al. Vitrification of human blastocysts with the Hemi-Straw carrier: application of assisted hatching after thawing. Hum Reprod 2003; 18: 1504–1511.
66. MartinoA, SongsasenN, LeiboS.Development into blastocysts of bovine oocytes cryopreserved by ultra-rapid cooling. Biol Reprod 1996; 54: 1059–1069.
67. HuangJYJ, ChenHY, TanSL, ChianR-C.Effect of choline-supplemented sodium-depleted slow freezing versus vitrification on mouse oocyte meiotic spindles and chromosome abnormalities. Fertil Steril 2007; 88: 1093–1100.
68. HuangJYJ, ChenHY, ParkJYS, TanSL, ChianR-C.Comparison of spindle and chromosome configuration in in vitro- and in vivo-matured mouse oocytes after vitrification. Fertil Steril 2008; 90: 1424–1432.
69. SteerCV, MillsCL, TanSL, CampbellS, EdwardsRG.The cumulative embryo score: a predictive embryo scoring technique to select the optimal number of embryos to transfer in an in-vitro fertilization and embryo transfer programme. Hum Reprod 1992; 7: 117–119.
70. ChildTJ, Abdul-JalilAK, TanSL.Embryo morphology, cumulative embryo score, and outcome in an oocyte in vitro maturation program. Fertil Steril 2002; 77: 424–425.
71. ChianR-C, KuwayamaM, TanL, TanJ, KatoO, NagaiT.High survival rate of bovine oocytes matured in vitro following vitrification. J Reprod Dev 2004; 50: 685–696.
72. DonnezJ, DolmansMM, DemylleD, et al. Restoration of ovarian function after orthotopic (intraovarian and periovarian) transplantation of cryopreserved ovarian tissue in a woman treated by bone marrow transplantation for sickle cell anaemia: case report.Hum Reprod 2006; 21: 183–188.
73. GunbyJ, DayaS.Assisted reproductive technologies (ART) in Canada: 2003 results from the Canadian ART Register. Fertil Steril 2007; 88: 550–559.
74. AndersenAN, GianaroliL, FelberbaumR, de MouzonJ, NygrenKG.Assisted reproductive technology in Europe, 2002. Results generated from European registers by ESHRE. Hum Reprod 2006; 21: 1680–1697.
75. ChianR-C, HuangJYJ, TanSL, et al. Obstetric and perinatal outcome in 200 infants conceived from vitrified oocytes. Reprod Biomed Online 2008; 16: 608–610.
76. American Cancer Society. Cancer Facts and Figures, 2006. Atlanta, GA: American Cancer Society, 2006.
77. RiesL, PercyC, BuninG. Introduction. In GurneyJ, LinetM, TamraT, YoungJ, BuninG, eds. Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975–1995. [NIH Pub No 99–4649.] Bethesda, MD: National Cancer Institute, 1999, pp. 1–15.
78. LoboRA. Potential options for preservation of fertility in women. N Engl J Med 2005; 353: 64–73.
79. BleyerW.The impact of childhood cancer on the United States and the world. Cancer 1990; 40: 355–367.
80. TulandiT, Al-TookS.Laparoscopic ovarian suspension before irradiation. Fertil Steril 1998; 70: 381–183.
81. OktayK, DemirtasE, SonWY, et al. In vitro maturation of germinal vesicle oocytes recovered after premature luteinizing hormone surge: description of a novel approach to fertility preservation. Fertil Steril 2008; 89: 228.e19–e22.
82. HuangJY, BuckettWM, GilbertL, TanSL, ChianR-C.Retrieval of immature oocytes followed by in vitro maturation and vitrification: a case report on a new strategy of fertility preservation in women with borderline ovarian malignancy. Gynecol Oncol 2007; 105: 542–544.
83. GidoniY, HolzerH, TanSL, TulandiT.Fertility preservation in non-oncologic patients. Reprod Biomed Online 2008;16: 792–800.
84. ElizurSE, ChianR, PineauCA, et al. Fertility preservation treatment for young women with autoimmune disease facing treatment with gonadotoxic agents. Rheumatology 2008; 47: 1506–1509.
85. ElizurSE, ChianR-C, HolzerHEG, et al. Cryopreservation of oocytes in a young woman with severe and symptomatic endometriosis: a new indication for fertility preservation. Fertil Steril 2009; 91: 293. e1–e3.
86. LauNM, HuangJYJ, MacDonaldS, et al. Feasibility of fertility preservation in young females with Turner syndrome. Reprod Biomed Online 2008; 17: 520–523.
87. HuangJY, TulandiT, HolzerH, et al. Cryopreservation of ovarian tissue and in-vitro matured oocytes in a female with mosaic Turner syndromeHum Reprod 2008; 23: 336–339.
88. HuangJY, TulandiT, HolzerH, et al. Increased maternal cardiovascular mortality associated with pregnancy in women with Turner syndrome. Fertil Steril 2006; 86: S127–S128.
89. GidoniYS, TakefmanJ, HolzerHEG, et al. Cryopreservation of a mother’s oocytes for possible future use by her daughter with Turner syndrome: case report. Fertil Steril 2008; 90: e9–e12.
90. HeffnerLJ.Advanced maternal age: how old is too old? N Engl J Med 2004; 351: 1927–1929.